April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Corneal Epitheliopathy Following Trabeculectomy With Intraoperative 5-Fluorouracil (5FU) or Mitomycin C (MMC) and Postoperative Adjunctive 5-Fluorouracil in 381 Patients
Author Affiliations & Notes
  • C. Reiter
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • S. Wimmer
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • A. Schultheiss
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • T. Klink
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • F. Grehn
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • G. Geerling
    Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany
  • Footnotes
    Commercial Relationships  C. Reiter, None; S. Wimmer, None; A. Schultheiss, None; T. Klink, None; F. Grehn, None; G. Geerling, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1956. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Reiter, S. Wimmer, A. Schultheiss, T. Klink, F. Grehn, G. Geerling; Corneal Epitheliopathy Following Trabeculectomy With Intraoperative 5-Fluorouracil (5FU) or Mitomycin C (MMC) and Postoperative Adjunctive 5-Fluorouracil in 381 Patients. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1956.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the incidence and longterm outcome of corneal surface defects and intraocular pressure following trabeculectomy with intraoperative 5FU and MMC and different dosages of postoperative (postOP) 5FU.

Methods: : A retrospective, non-randomized comparative study of 381 patients undergoing trabeculectomy with intraoperative application of either 5FU (group I, n=169) or MMC (group II, n=212). Depending on the Wuerzburg bleb classification score (WBCS) for postoperative scarring, of these 30 (group 2: n=26) patients did not receive 5FU postOP, 67 (93) received up to 7 postoperative injections of 5 mg 5FU and 72 (93) received more than 7 injections. Surface epithelial defects were routinely assessed by slitlamp microscopy and fluoresceine and intraocular pressure (IOP) was evaluated by Goldmann applanation tonometry. For statistical comparison the Kruskal-Wallis-Test and Chi-Square-test were used.

Results: : The mean total dose of 5FU was 25,8±9,1 mg (28,4±7,5 mg) with ≤ 7 injections and 54,2±10,9 mg 5FU (51,7±11,8mg) with >7 injections. Increasing dosage of postOP 5FU induced more frequently corneal erosions in both groups. Corneal erosions were seen in controls in 16,7% (26.9%), with ≤7 injections in 55,2% (47.3%) and with >7 injections in 77,8% (59.1%). The difference between the non-5FU, the low and high dose 5FU regimen was significant in group I as well as in group II (each p<0,0001). All groups showed a reduction of IOP to a lower normal range after 12 months. Control: 22,4mmHg to 13,4mmHg (22,6mmHg to 10,5mmHg), with ≤7 injections 23,8mmHg to 12,5mmHg (25mmHg to 11,5mmHg) and with >7 injections 25mmHg to 15,9mmHg (25,1mmHg to 13,6mmHg) (p=0,147 (p= 0,935)).

Conclusions: : Corneal epitheliopathy following trabeculectomy and postOP 5FU was dose dependent with higher doses leading to a higher incidence of corneal erosions. However 5FU-treatment of filtering blebs judged to be at high risk for scarring resulted in a similar final IOP lowering effect.

Keywords: cornea: epithelium • clinical (human) or epidemiologic studies: outcomes/complications • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×